CN Stock MarketDetailed Quotes

688302 Hinova Pharmaceuticals Inc.

Watchlist
  • 30.25
  • +0.62+2.09%
Market Closed May 31 15:00 CST
3.00BMarket Cap-11262P/E (TTM)

Hinova Pharmaceuticals Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hinova Pharmaceuticals Inc. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.48

+36.84%
Analyst Rating

Strong Buy

Jun 1, 2024

Hinova Pharmaceuticals Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 487.000M--
--2024/FY-- / 130.000M--
--2023/FY0.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 487.000M--
--2024/FY-- / 130.000M--
--2023/FY0.000 / 0.000--

Hinova Pharmaceuticals Inc. Earnings Reports

  • 2024 First Quarter Report

    Apr 26 12:00 ET

  • 2023 Annual Report Summary

    Apr 12 12:00 ET

  • 2023 ANNUAL REPORT

    Apr 12 12:00 ET

  • 2023 Annual Results Report Announcement

    Feb 23 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 1, 2024

    Strong Buy

    • Strong Buy

      71.43%

    • Buy

      28.57%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg